Volumetric

Drug development and biomedical research lack human-relevant tissue models with realistic multicellular structure and vascularization for accurate testing and screening.

Volumetric uses breakthrough 3D bioprinting to build living multicellular human tissues with complex blood vessel networks for patient-specific drug safety and efficacy testing and, longer term, organ replacement.

Pharmaceutical companies and biomedical researchers who need human tissue models for laboratory testing, screening, and drug development.